GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production ...Middle East

PR Newswire - News
GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production
Sterling to Manufacture GNX102-ADC for Planned Phase 1 Clinical Program NEW TAIPEI CITY, Taiwan, Nov. 12, 2024 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer...

Hence then, the article about glyconex announces manufacturing agreement with sterling for gnx102 adc clinical trial production was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production )

Apple Storegoogle play

Last updated :

Also on site :